| 000 | 01396 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512055425.0 | ||
| 264 | 0 | _c19860328 | |
| 008 | 198603s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/0002-9149(86)90810-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlein, M D | |
| 245 | 0 | 0 |
_aRegular formulation and sustained-release verapamil therapy in normotension and in mild to moderate hypertension. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cFeb 1986 |
||
| 300 |
_a69D-73D p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAngina Pectoris _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhysical Exertion |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aVerapamil _xadministration & dosage |
| 700 | 1 | _aWeiner, D A | |
| 700 | 1 | _aKellett, M A | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 57 _gno. 7 _gp. 69D-73D |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9149(86)90810-6 _zAvailable from publisher's website |
| 999 |
_c3519242 _d3519242 |
||